Lobbying Filing Details

Total Spending

$40,000

Activities

1

Lobbyists

1

Gov't Entities

2

Filing Information

Filing UUID:: 36a58de7-c8fd-4105-9d3a-46ce22af8dc8
Type:: Q1 - 1st Quarter - Report
Period:: 2021 - 1st Quarter (Jan 1 - Mar 31)
Date Posted:: April 16, 2021 at 9:46 PM
Income:: $40,000
Expenses:: $0
Document URL:: View Submission

Quick Info

Document Type: text/html
Posted By: Nicole Carelli

Registrant

BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ /THE DASCHLE GROUP

Law firm

Washington, District of Columbia

Client

CHIMERIX, INC.

Biopharmaceutical company.

North Carolina, United States of America

Lobbying Activities (1)

Activity 1

Health Issues

MCM development & procurement process; S. 415, A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to the scope of new chemical exclusivity.

Lobbyists (1)

NICOLE CARELLI

Government Entities (2)

SENATE
HOUSE OF REPRESENTATIVES

Source: LDA.gov, data retrieved November 5, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.